Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice

Behavioural Brain Research

Volumn 173, Issue 2, 2006, Pages 255-261

  Jardinaud, Fanny ^a,b,c   Roques, Bernard P ^c,d   Noble, Florence ^a,b,c  

^a CNRS   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d BICHAT HOSPITAL   (France)

Author keywords

Conditioned place preference; Locomotor activity; Morphine; Reward; Y maze

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; CANNABIS; DRONABINOL; LIGAND; MORPHINE;

ABSTINENCE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATION LEARNING; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; LOCOMOTION; LONG TERM EXPOSURE; LOW DRUG DOSE; MALE; MOTIVATION; MOUSE; NONHUMAN; OPIATE ADDICTION; PLACE PREFERENCE; PRIORITY JOURNAL; RECOGNITION; REINFORCEMENT; REWARD; TASK PERFORMANCE;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG TOLERANCE; MALE; MAZE LEARNING; MICE; MORPHINE; MOTOR ACTIVITY; PSYCHOTROPIC DRUGS; REINFORCEMENT (PSYCHOLOGY); TETRAHYDROCANNABINOL;

EID: 33747883874     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.06.027     Document Type: Article

References (30)

1. Bouaboula M., Poinot-Chazel C., Bourrie B., Canat X., Calandra B., Rinaldi-Carmona M., et al. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 312 Pt 2 (1995) 637-641
2. Breivogel C.S., Griffin G., Di Marzo V., and Martin B.R. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharm 60 (2001) 155-163
3. Cadoni C., and Di Chiara G. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience 90 (1999) 447-455
4. Cadoni C., Pisanu A., Solinas M., Acquas E., and Di Chiara G. Behavioural sensitization after repeated exposure to delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology (Berl) 158 (2001) 259-266
5. Corchero J., Romero J., Berrendero F., Fernandez-Ruiz J., Ramos J.A., Fuentes J.A., et al. Time-dependent differences of repeated administration with delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen. Brain Res Mol Brain Res 67 (1999) 148-157
6. Dellu F., Contarino A., Simon H., Koob G.F., and Gold L.H. Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol Learn Mem 73 (2000) 31-48
7. Derkinderen P., Valjent E., Toutant M., Corvol J.C., Enslen H., Ledent C., et al. Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J Neurosci 23 (2003) 2371-2382
8. Di Marzo V., Breivogel C.S., Tao Q., Bridgen D.T., Razdan R.K., Zimmer A.M., et al. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J Neurochem 75 (2000) 2434-2444
9. Ghozland S., Matthes H.W., Simonin F., Filliol D., Kieffer B.L., and Maldonado R. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J Neurosci 22 (2002) 1146-1154
10. Hampson R.E., and Deadwyler S.A. Cannabinoids, hippocampal function and memory. Life Sci 65 (1999) 715-723
11. Hernandez P.J., Sadeghian K., and Kelley A.E. Early consolidation of instrumental learning requires protein synthesis in the nucleus accumbens. Nat Neurosci 5 (2002) 1327-1331
12. Hoffman A.F., Oz M., Caulder T., and Lupica C.R. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. J Neurosci 23 (2003) 4815-4820
13. Lamarque S., Taghzouti K., and Simon H. Chronic treatment with delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin implications for vulnerability to drug addiction. Neuropharmacology 41 (2001) 118-129
14. Law P.Y., Wong Y.H., and Loh H.H. Molecular mechanisms and regulation of opioid receptor signaling. Ann Rev Pharm Toxicol 40 (2000) 389-430
15. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., et al. Unresponsiveness to cannabinoids and reduced addictives effects of opiates in CB1 receptor knockout mice. Science 283 (1999) 401-404
16. Liu J.G., and Anand K.J. Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 38 (2001) 1-19
17. Lu L., Zeng S., Liu D., and Ceng X. Inhibition of the amygdala and hippocampal calcium: calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in rats. Neurosci Lett 291 (2000) 191-195
18. Manzanares J., Corchero J., Romero J., Fernandez-Ruiz J.J., Ramos J.A., and Fuentes J.A. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharm Sci 20 (1999) 287-294
19. Manzanedo C., Aguilar M.A., Rodriguez-Arias M., Navarro M., and Minarro J. Cannabinoid agonist-induced sensitisation to morphine place preference in mice. Neuroreport 15 (2004) 1373-1377
20. Martin M., Ledent C., Parmentier M., Maldonado R., and Valverde O. Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur J Neurosci 12 (2000) 4038-4046
21. Mas Nieto M., Pommier B., Tzavara E., Caneparo A., Da Nascimento S., Le Fur G., et al. Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction. Brit J Pharm 132 (2001) 1809-1816
22. Norwood C.S., Cornish J.L., Mallet P.E., and McGregor I.S. Pre-exposure to the cannabinoid receptor agonist CP 55,940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. Eur J Pharm 465 (2003) 105-114
23. Rauhala P., Idanpaan-Heikkila J.J., Tuominen R.K., and Mannisto P.T. Differential disappearance of tolerance to thermal, hormonal and locomotor effects of morphine in the male rat. Eur J Pharm 285 (1995) 69-77
24. Rubino T., Vigano D., Massi P., Spinello M., Zagato E., Giagnoni G., et al. Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions. Neuropharmacology 39 (2000) 1331-1336
25. Singh M.E., McGregor I.S., and Mallet P.E. Repeated exposure to delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity. Neuropharmacology 49 (2005) 1189-1200
26. Solinas M., Panlilio L.V., and Goldberg S.R. Exposure to delta-9-tetrahydrocannabinol (THC) increases subsequent heroin taking but not heroin's reinforcing efficacy: a self-administration study in rats. Neuropsychopharmacology 29 (2004) 1301-1311
27. Tanda G., and Goldberg S.R. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data. Psychopharmacology (Berl) 169 (2003) 115-134
28. Tirelli E., Laviola G., and Adriani W. Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents. Neurosci Biobehav Rev 27 (2003) 163-178
29. Valverde O., Noble F., Beslot F., Dauge V., Fournie-Zaluski M.C., and Roques B.P. Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. Eur J Neurosci 13 (2001) 1816-1824
30. Varvel S.A., Hamm R.J., Martin B.R., and Lichtman A.H. Differential effects of delta 9-THC on spatial reference and working memory in mice. Psychopharmacology (Berl) 157 (2001) 142-150